Media-OutReach Newswire Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins
25% on Japan and Malaysia, 40% on Laos: US President Trump’s tariff letters to Asia add pressure for deals by Aug 1 5.